Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor

Journal of Bone and Mineral Research

Volumn 11, Issue 11, 1996, Pages 1736-1744

  Vargas, Socorro J ^a,b   Naprta, Anica ^a,b   Glaccum, Moira ^c   Lee, Sun Kyeong ^a,b   Kalinowski, Judith ^a,b   Lorenzo, Joseph A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL TISSUE; ARTICLE; CALVARIA; CONTROLLED STUDY; HUMERUS; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION;

EID: 0029926517     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650111117     Document Type: Article

References (28)

1. Lorenzo JA 1991 The role of cytokines in the regulation of local bone resorption. Crit Rev Immunol 11:195-213.
2. Yoneda T 1993 Cytokines in bone: Local translators in cell-to-cell communications. In: Noda M (ed.) Cellular and Molecular Biology of Bone. Academic Press, New York, NY, U.S.A., pp. 375-412.
3. Dinarello CA 1991 Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
4. Kuno K, Matsushima K 1994 The IL-1 receptor signaling pathway. J Leukocyte Biol 56:542-547.
5. Garrett IR, Guise TA, Bonewald LF, Chizzonite R, Mundy GR 1993 Evidence that interleukin-1 mediates its effects on bone resorption via the 80 kilodalton interleukin-1 receptor. Calcif Tissue Int 52:438-441.
6. Tartaglia LA, Goeddel DV 1992 Two TNF receptors. Immunol Today 13:151-153.
7. Heller RA, Krönke M 1994 Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9.
8. Tartaglia LA, Pennica D, Goeddel DV 1993 Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268:17542-18548.
9. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W 1995 Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913.
10. Rothe J, Lesslauer W, Lötscher H, Lang Y, Koebel P, Köntgen F, Althage A, Zinkernagel R, Steinmetz M, Bleuthmann H 1993 Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
11. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, PittsMeek S, Gillett N, Sheehan KCF, Schreiber RD, Goeddel DV, Moore MW 1994 Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563.
12. Feyen JHM, Elford P, Di Padova FE, Trechsel U 1989 Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res 4:633-638.
13. Lowik CWGM, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OLM, Arden LA, Papapoulos SE 1989 Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162:1546-1552.
14. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, Hirano T, Kishimoto T, Suda T 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303.
15. Majzoub JA, Muglia LJ 1995 Knockout mice. New Engl J Med 334:904-907.
16. Zeller R 1989 Fixation, embedding, and sectioning of tissues, embryos, and single cells. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strahl K (eds.) Current Protocols in Molecular Biology. John Wiley and Sons, New York, NY, U.S.A., pp. 14.1.1-14.1.8.
17. Bancroft JD 1990 Enzyme histochemistry. In: Bancroft JD, Stevens A (eds.) Theory and Practice of Histological Techniques. Churchill Livingstone, London, U.K., pp. 379-399.
18. Luna LG 1968 Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology, 3rd Ed. McGraw-Hill, New York, NY, U.S.A., pp. 32-46.
19. Kimmel DB, Jee WSS 1983 Measurements of area, perimeter, and distance: Details of data collection in bone histomorphometry. In: Recker RR (ed.) Bone Histomorphometry: Techniques and Interpretation. CRC Press, Boca Raton, FL, U.S.A., pp. 89-108.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595-610.
21. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382.
22. Lee SK, Goldring SR, Lorenzo JA 1995 Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136:4572-4581.
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
24. Sambrook J, Fritsch EF, Maniatis T (eds.) 1989 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY, U.S.A.
25. Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA 1989 Ovarian steroid treatment blocks a postmenopausal increased in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
26. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV 1991 Effect of surgical menopause and estrogen replacement in cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
27. Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R 1994 Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mic. J Clin Invest 94:2397-2406.
28. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R 1995 Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136:3054-3061.